Vicarious Surgical Inc Stock Price, News & Analysis

Vicarious Surgical Inc. (NYSE: RBOT, RBOT WS) announced it will release its financial results for the first quarter ended March 31, 2023, on May 8, 2023, after market close. The company will host a conference call at 4:30 p.m. Eastern Time to discuss these results. Vicarious Surgical is focused on advanced surgical robotics with the aim of enhancing surgical efficiency, improving patient outcomes, and reducing healthcare costs. Backed by prominent investors, including Bill Gates and Khosla Ventures, the company is known for its innovative approach that transports surgeons inside patients for minimally invasive surgeries. Stakeholders can access further information via the company's investor website.

Vicarious Surgical Inc. (NYSE: RBOT, RBOT WS) has announced its participation in two upcoming investor conferences. The company aims to enhance surgical procedures through innovative robotics technology.

The first event is the Cowen 43rd Annual Healthcare Conference, featuring a fireside chat on March 8th at 9:50 a.m. ET. The second is the Oppenheimer 33rd Annual Healthcare Conference, with a virtual presentation scheduled for March 14th at 1:20 p.m. ET. Live and archived versions of these presentations will be available on the company's website.

Vicarious Surgical reported a cash burn of $67 million for 2022, meeting its objective, and announced initiatives to extend its cash runway. The company expects 2023 cash burn between $55-$65 million. Vicarious Surgical's operating expenses surged to $80.1 million in 2022 versus $38.2 million in 2021, with an adjusted net loss of $78.8 million, or $0.65 per share. Despite a GAAP net income of $5.2 million for the year, the company reported significant losses. Notable achievements include the completion of the Beta 2 robotic system and partnerships with major healthcare providers, enhancing its market position.

Vicarious Surgical Inc. (NYSE: RBOT, RBOT WS) will report its financial results for the fourth quarter and full year ended December 31, 2022, after market close on February 13, 2023. A conference call will follow at 4:30 p.m. ET for management to discuss the results. Investors can join by calling +1 (646) 904 5544 domestically or +1 (929) 526 1599 internationally. The company develops advanced surgical robotics aimed at improving the efficiency of procedures and reducing costs, using proprietary technology to perform minimally invasive surgeries.

Vicarious Surgical Inc. (NYSE:RBOT) has appointed Dr. Victoria Carr-Brendel to its Board of Directors as of January 23, 2023. Dr. Carr-Brendel brings over 24 years of experience in medical device development and leadership roles, including her current position at Sonova Group. Her expertise is expected to enhance the company's efforts in bringing innovative surgical solutions to market. The announcement also includes the resignation of Phil Liang, a technology-focused venture capitalist. The company aims to improve surgical procedures' efficiency, outcomes, and costs through its unique robotic systems.